The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Maalox Plus Chewable Tablets 200mg/200mg/25mg



Opella Healthcare France SAS T/A SanofiPA23180/008/002

Main Information

Trade NameMaalox Plus Chewable Tablets 200mg/200mg/25mg
Active SubstancesALUMINIUM OXIDE, HYDRATED PH. EUR
MAGNESIUM HYDROXIDE PH. EUR.
Dimeticone ph. eur. (as simeticone ph. eur.)
Dosage FormChewable tablet
Licence HolderOpella Healthcare France SAS T/A Sanofi
Licence NumberPA23180/008/002

Group Information

ATC CodeA02AF Antacids with antiflatulents
A02AF02 ordinary salt combinations and antiflatulents

Status

Authorised/WithdrawnAuthorised
Licence Issued10/11/1975
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back